-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharma Network October 23rd, October 19th, the official website of the State Drug Administration shows that Sichuan Colum Pharmaceuticals has been approved for production and evaluated as follows by the imitation of four declared hydrochloric acid Moxiza tablets (receiving number CYHS1800545).
meters intranet data show that in 2019 China's public medical institutions and urban retail pharmacy terminals total market size of more than 1 billion yuan, the original research manufacturer Bayer accounted for 90% of the market.
is an antibacterially active 8-methyl fluoroquinoquinol broad-spectrum antimicrobial drug, mainly used to treat upper and lower respiratory tract infections.
the main dosage forms of hydrochloric acid moxisa star, which are currently listed in China, are injections, tablets and eye drops.
Figure 1: Sales of moxiza tablets in china's public medical institutions and urban retail pharmacies Terminal (units: 100 million yuan) Source: Mienet Database Minet Data show that in 2019 China's urban public hospitals, county-level public hospitals The total sales of the terminals of urban community centers and township hospitals (China's public medical institutions) and the terminals of urban retail pharmacies exceeded 1 billion yuan, an increase of 23.54 percent year-on-year, with Bayer accounting for more than 90 percent of the market share.
Figure 2: Review of hydrochloric acid Moxiza tablets Source: Minenet Consistency Evaluation Database Table: Hydrochloric Acid Mosisa Stars reported in the new classification Source: Minnet MED2.0 China Drug Review Database Minet Data At present, there are currently 9 enterprises such as East Sunshine Medicine, Xinlitai hydrochloric acid Moxisha star tablets through or as if through the consistent evaluation, the Middle East Sunshine Medicine as the first review;
: Data statistics as of October 21, if there are omissions, welcome to point out!